Scemblix-H-C-PSUSA-00011008-202210 EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation(s)
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
scientific-conclusion
medication.label.permit_number
EMA/348807/2023
medication.label.permit_validity
First published: 2023-09-22T16:21:00Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live